2 news items
Gritstone bio Reports First Quarter 2024 Financial Results and Provides Corporate Updates
GRTS
9 May 24
to EDGE™ (tumor antigen identification platform that was recently enhanced using large language models) highlight Gritstone's leadership
Gritstone bio Announces Appointment of Stephen Webster to its Board of Directors
GRTS
29 Apr 24
, a biopharmaceutical company, from 2008 until its acquisition by Cubist Pharmaceuticals in 2011. He also served in leadership positions in the investment banking
- Prev
- 1
- Next